Naproxol 750 embodies a significant case study within the biochemical pharmacy field. Its mechanism of effect fundamentally targets cyclooxygenase catalysts , specifically COX-1 , alleviating the generation of prostaglandins . Given a molecular analysis, Relafen's therapeutic potential copyrights on the ability to preferentially inhibit inflammatio